Heartland Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-578
| Closed | -$412K | – | 182 |
|
|
2024
Q4 | $412K | Sell |
578
-30
| -5% | -$21.4K | 0.22% | 92 |
|
|
2024
Q3 | $639K | Sell |
608
-16
| -3% | -$16.8K | 0.34% | 71 |
|
|
2024
Q2 | $656K | Sell |
624
-286
| -31% | -$301K | 0.37% | 63 |
|
|
2024
Q1 | $876K | Buy |
910
+4
| +0.4% | +$3.85K | 0.51% | 45 |
|
|
2023
Q4 | $796K | Sell |
906
-86
| -9% | -$75.5K | 0.55% | 44 |
|
|
2023
Q3 | $816K | Buy |
992
+87
| +10% | +$71.6K | 0.64% | 36 |
|
|
2023
Q2 | $650K | Buy |
905
+480
| +113% | +$345K | 0.51% | 51 |
|
|
2023
Q1 | $349K | Sell |
425
-543
| -56% | -$446K | 0.26% | 106 |
|
|
2022
Q4 | $698K | Buy |
968
+1
| +0.1% | +$721 | 0.52% | 44 |
|
|
2022
Q3 | $666K | Sell |
967
-135
| -12% | -$93K | 0.64% | 49 |
|
|
2022
Q2 | $651K | Buy |
1,102
+68
| +7% | +$40.2K | 0.58% | 57 |
|
|
2022
Q1 | $722K | Buy |
1,034
+711
| +220% | +$496K | 0.55% | 61 |
|
|
2021
Q4 | $204K | Buy |
+323
| New | +$204K | 0.15% | 125 |
|
|
2021
Q2 | – | Sell |
-1,623
| Closed | -$768K | – | 150 |
|
|
2021
Q1 | $768K | Buy |
1,623
+570
| +54% | +$270K | 0.7% | 48 |
|
|
2020
Q4 | $509K | Buy |
+1,053
| New | +$509K | 0.45% | 66 |
|